Overview

Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis

Status:
Completed
Trial end date:
2017-09-29
Target enrollment:
Participant gender:
Summary
A Randomized, Double-Blind, Vehicle-Controlled, Parallel-Design, Multiple-Site, Phase III Clinical Study to Evaluate the Efficacy and Safety of DSXS topical product in Patients with Mild to Severe Scalp Psoriasis
Phase:
Phase 3
Details
Lead Sponsor:
Taro Pharmaceuticals USA